The dangers of Pharma sponsored direct-to-consumer telehealth pathways for diagnosing Alzheimer’s and prescribing monoclonal antibodies.
#medsky
www.medscape.com/viewarticle/...
Concerns Raised Over DTC Platform for Alzheimer’s Diagnosis
Some neurologists and a consumer watchdog worry that an Eli Lilly–affiliated direct-to-consumer telehealth platform for Alzheimer’s could lead to misdiagnosis or unnecessary treatment.
